Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...
The U.S. Food and Drug Administration is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.
Sharonville, Ohio, celebrates the opening of the new Cincinnati Children's Applied Gene and Cell Therapy Center.
Sarepta must also run a post-marketing study for Elevidys to better assess the risk of serious liver injury in patients dosed ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
A rare disease that has cut off children from the outside world now potentially has a cure. A clinical trial to treat severe ...
Health and Me on MSN
Duchenne Gene Therapy: Why The FDA Has Tightened Rules Following Two Teen Deaths
The FDA has added a boxed warning to Sarepta’s Duchenne gene therapy Elevidys after two teens died from liver failure and has ...
WYFF News 4 on MSN
Greer, South Carolina, family hosts fundraiser for gene therapy to treat children with rare disorder
A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...
MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...
Hyderabad: BRIC-Translational Health Science and Technology Institute (BRIC-THSTI), in collaboration with Miltenyi Biotec and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback